GlassScriptPhysician profile
Howard Oriba
NPI 1891781530
$716.22
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $149 · 2023: $15.33 · 2024: $14.46.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $29.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $185.94 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $151.54 | 2019-2020 | |
| Janssen Biotech, INC. | $71.51 | 2019-2020 | |
| Lilly USA, LLC | $71.04 | 2019 | |
| Pfizer INC. | $61.55 | 2019-2020 | |
| Abbvie INC. | $46.16 | 2020 | |
| Genzyme Corporation | $40.38 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $33.62 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $24.69 | 2019 | |
| Dermavant Sciences, INC. | $15.33 | 2023 | Vtama |
| Incyte Corporation | $14.46 | 2024 | Opzelura |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Oriba listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.